UBS Group Portfolio holdings
UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Morningstar Mid-Cap ETF
VO
|
+$511M |
| 2 |
Vanguard Intermediate-Term Treasury ETF
VGIT
|
+$419M |
| 3 |
Vanguard Short-Term Treasury ETF
VGSH
|
+$353M |
| 4 |
SPDR Gold Trust
GLD
|
+$285M |
| 5 |
TWTR
Twitter, Inc.
TWTR
|
+$258M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$1.21B |
| 2 |
iShares US Treasury Bond ETF
GOVT
|
+$1.14B |
| 3 |
Microsoft
MSFT
|
+$1.08B |
| 4 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$790M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$401M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 10.78% |
| 2 | Healthcare | 6.25% |
| 3 | Consumer Discretionary | 6.24% |
| 4 | Financials | 5.99% |
| 5 | Communication Services | 4.57% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4251
M/I Homes
MHO
$3.74B
| $441K | ﹤0.01% |
12,793
+4,109
| +47% | +$112K |
|
|
MAGN
4252
Magnera Corp
MAGN
$466M
| $441K | ﹤0.01% |
2,113
-302
| -13% | -$57.3K |
|
|
CODX
4253
Co-Diagnostics
CODX
$5.53M
| $440K | ﹤0.01% |
759
+751
| +9,388% | +$343K |
|
|
NSLR
4254
Neostellar Capital Corp
NSLR
$273M
| $440K | ﹤0.01% |
61,920
-34,046
| -35% | -$191K |
|
4255
Douglas Dynamics
PLOW
$984M
| $439K | ﹤0.01% |
12,485
-5,699
| -31% | -$198K |
|
|
QVMT
4256
Invesco S&P 500 Concentrated QVM ETF
QVMT
$135M
| $439K | ﹤0.01% |
15,737
-340
| -2% | -$9.16K |
|
|
SRNE
4257
DELISTED
Sorrento Therapeutics, Inc.
SRNE
| $439K | ﹤0.01% |
69,947
-28,092
| -29% | -$108K |
|
|
TBI
4258
Trueblue
TBI
$323M
| $438K | ﹤0.01% |
28,681
-126,288
| -81% | -$1.88M |
|
|
PTR
4259
DELISTED
PETROCHINA COMPANY LIMITED ADS (REP 100 H SHARES)
PTR
| $438K | ﹤0.01% |
13,255
-26,819
| -67% | -$947K |
|
|
GTT
4260
DELISTED
GTT Communications, Inc.
GTT
| $438K | ﹤0.01% |
53,625
-15,715
| -23% | -$142K |
|
|
RC
4261
Ready Capital
RC
$333M
| $434K | ﹤0.01% |
49,944
-1,431
| -3% | -$9.73K |
|
4262
Preformed Line Products
PLPC
$2.26B
| $433K | ﹤0.01% |
8,654
-1,721
| -17% | -$83.8K |
|
|
AIF
4263
DELISTED
Apollo Tactical Income Fund Inc.
AIF
| $433K | ﹤0.01% |
34,916
-31,596
| -48% | -$375K |
|
4264
Royalty Pharma
RPRX
$25.8B
| $432K | ﹤0.01% |
+8,901
| New | +$441K |
|
4265
Standex International
SXI
$3.98B
| $432K | ﹤0.01% |
7,496
-1,218
| -14% | -$61.8K |
|
|
COHR
4266
DELISTED
Coherent Inc
COHR
| $432K | ﹤0.01% |
3,300
+920
| +39% | +$120K |
|
|
FRTA
4267
DELISTED
Forterra, Inc
FRTA
| $432K | ﹤0.01% |
38,681
-2,611
| -6% | -$21.5K |
|
4268
Coherus Oncology
CHRS
$192M
| $431K | ﹤0.01% |
24,154
+3,352
| +16% | +$56.7K |
|
4269
Insmed
INSM
$29.4B
| $431K | ﹤0.01% |
15,666
-19,279
| -55% | -$457K |
|
4270
Central Pacific Financial
CPF
$991M
| $430K | ﹤0.01% |
26,836
+10,078
| +60% | +$160K |
|
4271
CALL
International Paper
IP
$21.9B
| $430K | ﹤0.01% |
12,883
-109,824
| -90% | -$3.5M |
|
4272
iShares MSCI Chile ETF
ECH
$1.05B
| $429K | ﹤0.01% |
17,026
-823
| -5% | -$20.4K |
|
4273
VanEck Emerging Markets High Yield Bond ETF
HYEM
$525M
| $429K | ﹤0.01% |
19,257
-2,368
| -11% | -$50K |
|
|
CSA
4274
DELISTED
VictoryShares US Small Cap Volatility Wtd ETF
CSA
| $428K | ﹤0.01% |
10,645
+836
| +9% | +$30.9K |
|
|
ARGO
4275
DELISTED
Argo Group International Holdings, Ltd.
ARGO
| $428K | ﹤0.01% |
12,285
-10,960
| -47% | -$366K |
|
Similar funds
UBS Group's Q2 2020 Portfolio in Review
As of Q2 2020, UBS Group held 8,813 positions worth $237B, up 12% from $212B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
UBS Group withdrew a net $17.5B in Q2 2020, closing 776 positions and reducing 4,001 holdings. Its most notable exit was Allergan plc, an estimated $1.21B position sold in full.
By sector, the portfolio is most concentrated in Technology at 11% of assets, up from 10% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, UBS Group opened a new position in Warner Music worth $87.9M.
- UBS Group's largest Q2 2020 buy was Warner Music: 2,981,053 shares worth $87.9M.
- UBS Group added most to Vanguard Morningstar Mid-Cap ETF in Q2 2020, an estimated $511M increase.
- UBS Group's biggest Q2 2020 reduction was iShares US Treasury Bond ETF, cutting an estimated $1.14B.
- UBS Group fully exited Allergan plc in Q2 2020, selling an estimated $1.21B.
- UBS Group's ten largest holdings make up 16% of its $237B portfolio in Q2 2020.
- UBS Group opened 706 new positions and closed 776 in Q2 2020.
- UBS Group's portfolio value rose 12% quarter-over-quarter to $237B.
Based on UBS Group's 13F filing for Q2 2020, filed 31 Jul 2020.